Decreasing FasL expression in tumor cells can reduce the apoptosis rate of immune cells and further block the apoptosis signal pathway of immune cells by preventing tumor necrosis factor-induced apoptosis, which may boost the survival rate of immune cells (109). Here, FASLG is linked to neoplasm.